Multidisciplinary Approach Successful in Chronic Back Pain

This article originally appeared here.
Share this content:
Multidisciplinary Approach Successful in Chronic Back Pain
Multidisciplinary Approach Successful in Chronic Back Pain

(HealthDay News) -- Medication combined with a multidisciplinary rehabilitation program can decrease disability and improve mental health in low back pain patients over several years, according to a study published online Dec. 26 in the International Journal of Rheumatic Diseases.

Sedigheh S. Tavafian, Ph.D., from Tarbiat Modares University in Tehran, Iran, and colleagues conducted an extended 30-month follow-up of participants of a clinical trial evaluating group-based rehabilitation plus drug treatment for low back pain. In the follow-up, 69 patients in the intervention group continued receiving monthly motivational consultation and booster classes plus oral medication, and 77 patients in the control group received medication alone.

The researchers found that the two groups showed improvement for all studied variables (evaluated using the Short Form 36, Quebec Disability Scale [QDS], and Ronald Morris Disability Questionnaire [RDQ]) over time up to 30 months. However, the intervention group had consistently better outcomes for all variables compared with the control group. Within each group there were significant differences by time for measures of mental health and disability measured through QDS and RDQ.

"The proposed multidisciplinary program could improve mental health and disability up to 30 months in chronic low back pain patients," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Lyme-Bearing Ticks More Widespread in U.S. Than Thought

Lyme-Bearing Ticks More Widespread in U.S. Than Thought

Disease-carrying ticks were detected in 83 counties where they'd never been found before

Availability of Generic Antivirals for Hepatitis B Increasing

Availability of Generic Antivirals for Hepatitis B Increasing

Drop in median price of WHO-prequalified generic tenofovir from $208 to $32 from 2004 to 2016

Visual Function Deficits Up in Developmental Dyslexia

Visual Function Deficits Up in Developmental Dyslexia

Increased prevalence of deficits in visual function versus typically developing school-age children

is free, fast, and customized just for you!




Already a member?

Sign In Now »